The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 06, 2023
Filed:
Jan. 08, 2021
Applicant:
Galapagos NV, Mechelen, BE;
Inventors:
Nicolas Luc Sabourault, Romainville, FR;
Piet Wigerinck, Mechelen, BE;
Assignee:
GALAPAGOS NV, Mechelen, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); H04W 4/80 (2018.01); H04L 9/40 (2022.01); H04L 67/104 (2022.01); H04W 8/24 (2009.01); H04L 67/51 (2022.01); A61K 31/437 (2006.01); A61K 31/541 (2006.01); A61K 45/06 (2006.01); H04W 92/18 (2009.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/437 (2013.01); A61K 31/541 (2013.01); A61K 45/06 (2013.01); H04L 63/0428 (2013.01); H04L 63/06 (2013.01); H04L 63/0861 (2013.01); H04L 63/205 (2013.01); H04L 67/104 (2013.01); H04L 67/51 (2022.05); H04W 4/80 (2018.02); H04W 8/24 (2013.01); C07B 2200/13 (2013.01); H04W 92/18 (2013.01);
Abstract
The present invention discloses salts of a Compound 1: useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases, proliferative diseases, allergy, transplant rejection, diseases involving degradation and/or disruption of cartilage homeostasis, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.